Basics Standard BioTools Inc. IPO Date: March 1, 2011 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $549.93M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.52% Avg Daily Range (30 D): $0.04 | 2.82% Avg Daily Range (90 D): $0.04 | 2.71% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): 1.37M Avg Daily Volume (90 D): 1.23M Trade Size Avg Trade Size (Sh.): 189 Avg Trade Size (Sh.) (30 D): 198 Avg Trade Size (Sh.) (90 D): 209 Institutional Trades Total Inst.Trades: 121 Avg Inst. Trade: $1.88M Avg Inst. Trade (30 D): $5.8M Avg Inst. Trade (90 D): $3.38M Avg Inst. Trade Volume: 1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.91M Avg Closing Trade (30 D): $.55M Avg Closing Trade (90 D): $.95M Avg Closing Volume: 1.56M     News Jul 21, 2025 @ 11:00 AM Standard BioTools Schedules Second Quarter Earning... Source: Marissa Bychir Apr 22, 2025 @ 11:00 AM Standard BioTools Schedules First Quarter Earnings... Source: N/A Jan 13, 2025 @ 12:00 PM Standard BioTools Announces Preliminary Fourth Qua... Source: N/A Dec 19, 2024 @ 1:00 PM Standard BioTools to Present at the 43rd Annual J.... Source: N/A Nov 7, 2024 @ 1:00 PM Standard BioTools Appoints Alex Kim as Chief Finan... Source: Standard Biotools Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.09 $-.09 $-.07 Diluted EPS $-.09 $-.09 $-.07 Revenue $ 19.55M $ 21.76M $ 40.8M Gross Profit $ 9.48M $ 10.63M $ 19.74M Net Income / Loss $ -34.69M $ -33.46M $ -26.03M Operating Income / Loss $ -32.94M $ -25.7M $ -32.97M Cost of Revenue $ 10.07M $ 11.13M $ 21.05M Net Cash Flow $ -29.2M $ 7.73M $ -15.35M PE Ratio